AMNEAL PHARMACEUTICALS ( NASDAQ:AMRX – Get Free Report ) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.06. AMNEAL PHARMACEUTICALS had a net margin of 0.12% and a negative return on equity of 189.49%. AMNEAL PHARMACEUTICALS has set its FY 2025 guidance at 0.700-0.750 EPS. Analysts forecast that AMNEAL PHARMACEUTICALS will post 0.53 earnings per share for the current fiscal year.